Type 2 Diabetes Drug Improves Vascular Insulin Sensitivity
American Physiological Society (APS)
Loyola Medicine Nephrologist Sylvester Barnes is available to discuss a new study which showed Ozempic cut the risk of kidney disease progression and related health complications in diabetic patients.
A landmark study conducted at four sites, including Joslin Diabetes Center, reports that people with type 2 diabetes who underwent bariatric surgery achieved better long-term blood glucose control compared to people who received medical management plus lifestyle interventions. Participants who underwent bariatric surgery, also called metabolic or weight-loss surgery, were also more likely to stop needing diabetes medications and had higher rates of diabetes remission up to 12 years post-surgery. The findings, published in JAMA, suggest that weight loss surgery may carry benefits for people with diabetes, even those who are below the traditional BMI threshold of 35 for bariatric surgery.
Endocrine Society members elected Carol Lange, Ph.D., of the University of Minnesota in Minneapolis, Minn., as its 2025-2026 President. She will serve as President-Elect for a year beginning in June 2024 before becoming President in June 2025.
Semaglutide is a safe, effective therapy for a common fatty liver disease in people with HIV, according to the results of a clinical trial presented by UTHealth Houston.
After spending more than three decades managing her diabetes, Pam Mirabile was alarmed by swelling in her foot. She visited Loyola Medicine podiatric surgeon Katherine Dux, DPM, who diagnosed her with Charcot foot, a rare complication of diabetes.
Alzheimer’s disease and Type 2 diabetes are part of a family of amyloid diseases that are characterized by having proteins that cluster together. University of Washington researchers have demonstrated more similarities between the two diseases.
People who are overall healthy and living with well-controlled Type 2 diabetes can donate a kidney, thanks to a change in national policy.
Better prevention of Type II diabetes could save both lives and money. The U.S. spends over $730 billion a year — nearly a third of all health care spending — on treating preventable diseases like diabetes.
A drug in clinical trials as a treatment for metabolic dysfunction-associated steatotic liver disease (MASLD) works with a one-two punch that shuts down triglyceride production and fatty acid synthesis in liver cells, UT Southwestern Medical Center researchers show in a new study.
Ochsner Digital Medicine has partnered with Humana Healthy Horizons to provide digital medicine services to its members.
Research by Cleveland Clinic and three other U.S. medical centers has found that bariatric surgery provides better long-term control of blood glucose levels in patients with obesity and type 2 diabetes, compared with medical therapy.
The screenings program wants to identify patients who are at risk of developing diabetes and connect them with resources that can help them manage their condition. The initiative aligns with the broader goal of integrating diabetes testing into routine screenings across dental clinics in our community.
Blood vessels constitute a closed pipe system distributed throughout the body, transporting blood from the heart to other organs and delivering metabolic waste products back to the lungs and kidneys. Changes in blood vessels are related to
About eight million people live with Type 1 diabetes (T1D) worldwide, a chronic autoimmune condition in which the body attacks and destroys its own insulin-producing β-cells (pronounced “beta”) in the pancreas, leading to a lack of insulin and inability to regulate blood sugar. It’s not known why the body suddenly perceives its own β-cells as the enemy; some lines of evidence suggest environmental factors such as viral infections may trigger the onset of T1D, others suggest genetics may also play some role. Groundbreaking research by investigators at Joslin Diabetes Center sheds new light on the specific changes β-cells go through at the onset of T1D. Their findings—published in Nature Cell Biology—offer new avenues for targeted interventions for the chronic autoimmune condition.
Glucagon, a hormone best known for promoting blood sugar production in the liver, also appears to play a key role in maintaining kidney health. When UT Southwestern Medical Center researchers removed receptors for this hormone from mouse kidneys, the animals developed symptoms akin to chronic kidney disease (CKD).
Diabetic patients who take anti-diabetic drugs - known as glitazones – long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University of Bristol has found.
Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.